跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZARELIS RETARD 37,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZARELIS RETARD 37,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
ZARELIS RETARD 37,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Italfarmaco S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 23, 2025
Approval ID
2c82eb7073589aa0
Company
Italfarmaco S.A.
Type
Standard
Approval Details
Approval Id
2c82eb7073589aa0
Drug Cima Aemps Name
ZARELIS RETARD 37,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
90066
Holder Company Name
Italfarmaco S.A.
Marketing Company Name
Italfarmaco S.A.
Holder Company Detail Path
/organization/italfarmaco-s-a
Marketing Company Detail Path
/organization/italfarmaco-s-a
Authorization Date
2025-01-23
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
37,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Italfarmaco S.A.
Company Detail Path
/organization/italfarmaco-s-a
Company Information
Pharmaceutical Company Name
Italfarmaco S A
Country Name
Chile
City Name
santiago,santiago,country_cl
Address
Encomenderos 161 3-B
Active Ingredients
VENLAFAXINA HIDROCLORURO
42,43 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 23, 2025
Approval ID
2c82eb7073589aa0
Type
Standard
Back to CIMA-AEMPS Approvals